Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

36 (14%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-18 2021-05-13 134343
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135974
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135977
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135980
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-25 2021-04-21 136341
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-08 2021-05-13 137185
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-05 2021-09-02 143722
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-27 2021-11-11 144755
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-09 2021-12-08 145446
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-16 2021-11-11 145791
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-MORPHINE SR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-10-29 160448
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-12-15 160454
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-01 2023-02-09 176854
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-22 2023-02-09 179303

Showing 81 to 100 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520

Showing 201 to 220 of 250